search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SUN CARE 95


Tinosorb (now referred to as ‘TSB’) S Lite Aqua is unique as a dispersion of the oil- soluble UV filter active BEMT. Figure 1 shows the absorbance spectra of several UV filters, including BEMT.


Incorporating BEMT into both the water and the oil phase boosts the SPF of a formulation while allowing manufacturers to reduce the oil phase, thus keeping the formulation light. This helps manufacturers avoid solubility issues due to an oil phase overload. Incorporated into the water phase, the aqueous dispersion forms a homogeneous film on the skin. The insolubility of BEMT in water ensures water resistance while supporting effective sun protection.


Tests and results Formulations containing the new BEMT- based cosmetic UV filter formulation have proven their performance and the formulation’s effect on water resistance in a series of in vivo and in vitro tests: SPF in vivo test ISO24444, UVA-PF in vitro test ISO24443, WR in vitro test according to internal BASF method No. 50, and WR in vivo test according to the Cosmetic Europe Water Resistance Guideline, Dec 2005. As a reference, a sunscreen formulation


(UV-DE-16-123-1-8) was prepared containing the UV-B filters Ethylhexyl Triazone (EHT, e.g. Uvinul®


T 150) at 2.0%


and Ethylhexyl Salicylate (EHS) at 5.0% as well the UV-A filter Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB, Uvinul A Plus) at 3.0% in the oil phase. Two further formulations were prepared containing an additional 2% BEMT (TSB S) in the oil phase (UV-DE-16-123-1-1) and an additional 2% BEMT (10% TSB S Lite Aqua equals 2% BEMT active) in the water phase (UV-DE-16-123-1-2), respectively. The respective protection factors that were achieved are given in Table 1, SPF in vivo and UVA-PF in vitro. The formulation containing no broad- spectrum UV filter (UV-DE-16-123-1-8)


1.6 1.4 1.2 1


0.8 0.6 0.4 0.2 0


290 Figure 2: Tinosorb® November 2019 320 S Lite Aqua boosts sun protection. PERSONAL CARE ASIA PACIFIC 350 Wavelenght (nm) 380


achieved an SPF in vivo of around 10 (12) and a UVA-PF in vitro of 5.1. By contrast, the formulation containing 2% BEMT (TSB S) in the oil phase (UV-DE-16-123-1-1) achieved an SPF in vivo of around 15 (13) and a UVA-PF in vitro of 7.3, while the one containing 10% TSB S Lite Aqua (equals 2% BEMT active) in the water phase (UV-DE-16- 123-1-2) reached an SPF in vivo of around 25 (23) and a UVA-PF in vitro of 11.2. The addition of 2% BEMT to the water phase effectively increased the sun protection values SPF and UVA-PF compared with adding 2% BEMT to the already loaded oil phase (Fig 2).


Selection of emollients To dissolve 4% BEMT (TSB S) in the oil phase, a large volume of polar oils is needed (Table 2, formulation UV-DE-16- 123-2-5). If just half of the BEMT can be transferred to the water phase (UV-DE-16- 123-2-9), formulators will have more flexibility to choose light emollients with high spreadability values, for lighter sensory properties (Table 2).


Enhancing water resistance To assess the effects of water-phase UV filters on a sunscreen’s water resistance (WR), three SPF 50+ formulations were prepared with


n UV-16-123-1-2 Tinosorb®


S Lite Aqua


Base + 10% Tinosorb® (2% BEMT in water phase)


n UV-16-123-1-1 BEMT


Base + 2% BEMT (Tinosorb® S)


n UV-16-123-1-8 Base 2.0% Ethylhexyl Triazone (EHT) 5.0% Ethylhexyl Salicylate (EHS) 3.0% Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB)


S Lite Aqua


Table 2: SPF in vivo and UVA-PF in vitro results UV filters


UVB filters Ethylhexyl Triazone (EHT, e.g. Uvinul®


T 150) Ethylhexyl Salicylate (EHS) UVA filter


Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB, Uvinul®


A Plus)


Broad- spectrum BEMT (Tinosorb®


Tinosorb® SPF in vivo


S) S Lite Aqua UVA-PF in vitro


– –


12 5.1


2.0% –


13 7.3 –


10.0% 23


11.2 % by weight 2.0% 5.0% 3.0% % by weight UV-DE-16-123-1-8 UV-DE-16-123-1-1 2.0% 5.0% 3.0% % by weight UV-DE-16-123-1-2 2.0% 5.0% 3.0%


Absorbance


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120